This site is intended for healthcare professionals only
LoginRegister
Despite SC, NMC orders, rabies immunoglobulin missing in major BMC hospitalsUSFDA approves commercial production of Vasostrict at Endo newest Indore facility
NPPA Panel Defers Biological Es Pneumonia Vaccine Price Exemption, Seeks ClarificationRevise protocol for conducting Phase I CT in India: CDSCO Panel Tells Biological E on Typhoid and...
positive phase 3 trialCDSCO Waives Local Clinical Trials for Drugs Approved in Select Countries: Health Minister
Alembic Pharma Gets USFDA Final Approval for Parkinsons Drug Stalevo Generic6 step-down subsidiaries of Alembic Pharma dissolves
NGT seeks response from Environment Ministry on Hyderabad pharma unit blastNGT seeks response from Environment Ministry on Hyderabad pharma unit blast
Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to StelaraBiocon gets EIR with VAI status from USFDA for Bengaluru API facility
Novartis concludes acquisition of Tourmaline BioUS Appeals Court decision favors MSN Pharma in Novartis heart drug Entresto generic dispute
Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun PharmaConduct phase III clinical study on resistant hypertension: CDSCO Panel tells Sun Pharmaceutical...
Zydus Bags USFDA Nod for Eltrombopag Tablets Across Four StrengthsZydus Lifscience gets CDSCO Panel nod to study Rabies Vaccine
CDSCO Expert Panel Backs Akums Faropenem Dispersible Tablets, Grants CT, BE WaiversAkum Drugs & Pharmaceutical gets CDSCO Panel nod for BE study of FDC Eplerenone plus Torsemide...
Jubilant Generics invests Rs 20 lakh in Jubilant Pharma CanadaLaurus Bio secures equity infusion of Rs 120 crore
Shilpa Medicare ink pact to sell 31 percent stake in Sravathi Advanced Process Technologies for Rs 49.6 croreTeva to divest Teva-Takeda, its Business Venture in Japan
X